These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16162906)

  • 21. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis.
    Niewold TB; Harrison MJ; Paget SA
    QJM; 2007 Apr; 100(4):193-201. PubMed ID: 17434910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of a new fluorometric immunoassay for the detection of anti-cyclic citrullinated peptides autoantibodies in rheumatoid arthritis].
    Dubois-Galopin F; Masson C; Chevailler A
    Ann Biol Clin (Paris); 2006; 64(2):162-5. PubMed ID: 16556527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does a positive anti-CCP test identify a distinct arthritis entity?
    Skogh T
    Arthritis Res Ther; 2005; 7(6):230-2. PubMed ID: 16277697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
    Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
    Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative clinical rheumatology: why is a test for anti-CCP antibodies included in most routine care for rheumatoid arthritis while a HAQ/MDHAQ remains largely a research tool?
    Pincus T; Yazici Y; Bergman MJ
    J Rheumatol; 2009 Aug; 36(8):1563-4. PubMed ID: 19671805
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.
    Korkmaz C; Us T; Kaşifoğlu T; Akgün Y
    Clin Biochem; 2006 Oct; 39(10):961-5. PubMed ID: 16979149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
    Qing YF; Zhang QB; Zhou JG; Yuan GH; Wei J; Xing Y; Liu JP; Jiang L; Chen JP
    Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Very early 'Rheumatoid' arthritis cohorts: limited by selection.
    Inanc M
    Rheumatology (Oxford); 2007 Feb; 46(2):185-7. PubMed ID: 17043049
    [No Abstract]   [Full Text] [Related]  

  • 32. [immunological and serological tests for diagnosis of rheumatoid arthritis: antinuclear antibodies].
    Hirakata M; Kaneko Y
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():333-40. PubMed ID: 15799373
    [No Abstract]   [Full Text] [Related]  

  • 33. Classification criteria for rheumatoid arthritis--time to abandon rheumatoid factor?
    Symmons DP
    Rheumatology (Oxford); 2007 May; 46(5):725-6. PubMed ID: 17215261
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
    Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
    Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Early prediction of joint destruction in rheumatoid arthritis].
    Eguchi K
    Clin Calcium; 2007 Apr; 17(4):517-25. PubMed ID: 17404480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunological and serological tests for diagnosis of rheumatoid arthritis--introduction].
    Tanaka M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():310-2. PubMed ID: 15799368
    [No Abstract]   [Full Text] [Related]  

  • 37. [Predictive factors in prognosis of rheumatoid arthritis].
    Matsuda T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():19-23. PubMed ID: 15799311
    [No Abstract]   [Full Text] [Related]  

  • 38. Rheumatologic diagnostic serology: tests which test clinicians.
    Wong ML
    N Z Med J; 2004 Oct; 117(1203):U1095. PubMed ID: 15477919
    [No Abstract]   [Full Text] [Related]  

  • 39. Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis.
    Bugatti S; Caporali R; Manzo A; Sakellariou G; Rossi S; Montecucco C
    Ann Rheum Dis; 2012 Apr; 71(4):625-6. PubMed ID: 22039169
    [No Abstract]   [Full Text] [Related]  

  • 40. The window of opportunity in ACPA-positive rheumatoid arthritis is not explained by ACPA characteristics.
    Willemze A; van der Linden MP; le Cessie S; Trouw LA; Toes RE; Huizinga TW; van der Helm-van Mil AH
    Ann Rheum Dis; 2011 Sep; 70(9):1697-8. PubMed ID: 21482537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.